Study of Echocardiography Use in Managing Critically Ill Neonates Evaluating Outcomes and Recovery in Newborns with Hemodynamic Instability

What this Trial Is About

Researchers are studying critically ill neonates who show signs of hemodynamic instability to understand their outcomes, including mortality and illness severity. The study evaluates how echocardiography heart ultrasound can help manage these unstable newborns by tracking the time it takes for them to become stable again. This observational study compares unstable neonates to a control group of stable neonates to assess the impact of echocardiographic assessments. Neonates in the study receive detailed clinical examinations and echocardiographic assessments using a specialized device. Based on echocardiography results, treatments such as dobutamine, volume expansion, hydrocortisone, dopamine, epinephrine, or interventions for patent ductus arteriosus PDA may be given according to specific heart function findings. These procedures are repeated regularly, with daily echocardiographic follow-ups to monitor heart function and stability. Participants undergo continuous monitoring including clinical exams and repeated echocardiograms to evaluate heart function parameters like ejection fraction, ductus arteriosus condition, pulmonary hypertension, and cardiac indexes. These assessments occur daily or at set intervals to track progress. The study involves neonates from birth up to 28 days old, with care and data collection continuing until discharge to measure outcomes and safety throughout hospitalization.

Impact of Echocardiography on Management of Critically Ill Neonates